secwatch.observer — SEC 8-K summary
======================================

Issuer:     Niagen Bioscience, Inc. (NAGE)
CIK:        0001386570
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001386570-25-000025
Event type: other
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Niagen Bioscience authorizes $10M share repurchase program through October 2027
-------------------------------------------------------------------------------

- Board authorized up to $10M in common stock repurchases over ~2 years; expires Oct 31, 2027.
- Repurchases may occur in open market or private negotiations; no obligation to buy any shares.
- CEO Rob Fried states company is "an excellent investment" and program is compelling use of capital.
- Program may be modified, suspended, or terminated at any time at Board's discretion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1386570/000138657025000025/0001386570-25-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1386570/000138657025000025/cdxc-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001386570-25-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer